UBS Lux Equity Fund Biotech USD vs Aktiespararna Direktavkastning A

UBS Lux Equity Fund Biotech USD vs Aktiespararna Direktavkastning A

1. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    5

2. Aktiespararna Direktavkastning A

  • Security

    Aktiespararna Direktavkastning A

  • Fee

    0.30%

  • ISIN

    SE0008321780

  • Holdings

    5

Fund Holdings

We have information about 7 holdings in UBS Lux Equity Fund Biotech USD, where the largest holding is Regeneron Pharmaceuticals (10.04), followed by Moderna (9.21) and Gilead Sciences (4.66). In comparison with Aktiespararna Direktavkastning A, we have 6 holdings where Stora Enso is the largest holding (4.8), followed by JM (3.65) and Boliden (3.43).

All Holdings

Here we compare the holdings in UBS Lux Equity Fund Biotech USD and Aktiespararna Direktavkastning A.

UBS Lux Equity Fund Biotech USD Aktiespararna Direktavkastning A
1. Regeneron Pharmaceuticals Inc
10.04 %		 1. Stora Enso R
Finland
4.8 %
2. Moderna Inc
9.21 %		 2. JM
3.65 %
3. Gilead Sciences Inc
USA
4.66 %		 3. Boliden AB
Sweden
3.43 %
4. BioNTech SE
4.13 %		 4. Intrum AB
2.14 %
5. Karuna Therapeutics Inc
3.75 %		 5. SBB B
1.2 %

The list of fund holdings was last updated on September 10, 2025.